Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Plasma proteomics reveals that the biological ages of key organs, especially the brain and immune system, strongly predict ...

Internal medicine and rheumatology specialist Siobhan Deshauer, MD, does a deep dive on the signs of kidney disease. Following is a partial transcript of the video (note that errors are possible): ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising ...

For people with kidney failure, home dialysis can offer more freedom and better quality of life. So what’s stopping the NHS ...

Ardelyx's IBSRELA shows strong 57% sales growth, but faces stiff competition and uncertain sustainability. Click here to read ...

The hepatitis E virus (HEV) causes severe liver inflammation. A research team from Ruhr University Bochum, Germany, and ...

New research, presented at the ESOT Congress 2025, reveals persistent inequalities in children's access to life-saving kidney ...

By adopting FDA-endorsed endpoints that are easier to achieve, Dimerix has bolstered the chances of its pivotal kidney drug trial succeeding.

New research, presented at the ESOT Congress 2025, reveals persistent inequalities in children's access to life-saving kidney ...

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic ...